CLINICAL SIGNIFICANCE OF MEDICINAL PREPARATIONS REDUCING OXIDATIVE STRESS IN THE HUMAN BODY
O`ktamova N.B
Tashkent City Alfraganus University Faculty of Medicine, General Medicine Program 3rd-year Student
Boymuratov F.T
Tashkent City Alfraganus University Faculty of Medicine, Department of Pharmacy and Chemistry Associate Professor
Keywords: Keywords: Oxidative stress; antioxidants; reactive oxygen species; redox balance; pharmacotherapy; clinical significance; free radicals; cellular protection.
Abstract
Abstract: Oxidative stress, caused by an imbalance between the production of reactive oxygen species (ROS) and the antioxidant defense system, plays a key role in the development of numerous chronic and degenerative diseases. The regulation of oxidative processes through pharmacological and natural antioxidant preparations has become a central focus of modern biomedical research. Medicinal substances that reduce oxidative stress, including vitamins (C, E), polyphenols, flavonoids, and enzymatic antioxidants such as superoxide dismutase, have demonstrated significant clinical benefits in preventing cellular damage, inflammation, and premature aging. Clinical studies show that targeted antioxidant therapy can improve cardiovascular health, enhance immune function, and support neurological stability. The clinical significance of these agents lies in their potential to maintain redox homeostasis and prevent disease progression when used appropriately and under medical supervision.
References
1. Halliwell, B., & Gutteridge, J. M. C. (2015). Free Radicals in Biology and Medicine. 5th Edition. Oxford University Press.
2. Lobo, V., Patil, A., Phatak, A., & Chandra, N. (2010). Free radicals, antioxidants and functional foods: Impact on human health. Pharmacognosy Reviews, 4(8), 118–126.
3. Sies, H. (2017). Oxidative stress: A concept in redox biology and medicine. Redox Biology, 4, 180–183.
4. Poljsak, B., & Milisav, I. (2019). Clinical implications of oxidative stress and antioxidant supplementation. Oxidative Medicine and Cellular Longevity, 2019, Article ID 5847496.
5. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. International Journal of Biochemistry & Cell Biology, 39(1), 44–84.
6. Ray, P. D., Huang, B. W., & Tsuji, Y. (2012). Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cellular Signalling, 24(5), 981–990.
7. Giustarini, D., Dalle-Donne, I., Milzani, A., Tsikas, D., & Rossi, R. (2009). Oxidative stress and human diseases: Origin, link, measurement, mechanisms, and biomarkers. Critical Reviews in Clinical Laboratory Sciences, 46(5–6), 241–281.
8. Finkel, T., & Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature, 408(6809), 239–247.
9. Sies, H., Berndt, C., & Jones, D. P. (2017). Oxidative stress: From basic research to clinical application. The American Journal of Medicine, 130(9), 1355–1360.
10. Pham-Huy, L. A., He, H., & Pham-Huy, C. (2008). Free radicals, antioxidants in disease and health. International Journal of Biomedical Science, 4(2), 89–96.